Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Dense breasts: What it means and what women can do about screening

2.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

3.

The risk of lung cancer recurrence is linked to hypoxemia brought on by sleep apnea.

4.

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

5.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot